Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis.
Kalia LV, Asis A, Arbour N, Bar-Or A, Bove R, Di Luca DG, Fon EA, Fox S, Gan-Or Z, Gommerman JL, Kang UJ, Klawiter EC, Koch M, Kolind S, Lang AE, Lee KK, Lincoln MR, MacDonald PA, McKeown MJ, Mestre TA, Miron VE, Ontaneda D, Rousseaux MWC, Schlossmacher MG, Schneider R, Stoessl AJ, Oh J.
Kalia LV, et al. Among authors: lincoln mr.
Nat Rev Neurol. 2024 Oct 7. doi: 10.1038/s41582-024-01023-0. Online ahead of print.
Nat Rev Neurol. 2024.
PMID: 39375563
Review.